Psychological interventions for people with cystic fibrosis and their families

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Glasscoe, Claire A ^a   Quittner, Alexandra L ^b  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b Department of Biology   (United States)

Author keywords

*Psychotherapy; Adult; Child; Cystic fibrosis *therapy ; Humans; Randomized controlled trials as topic

Indexed keywords

ANTHROPOMETRY; BEHAVIOR CONTRACTING; BEHAVIOR THERAPY; CALORIC INTAKE; CLINICAL TRIAL; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DIETARY INTAKE; EMOTION; FAMILY COUNSELING; FAMILY THERAPY; FEEDBACK SYSTEM; FUNCTIONAL ASSESSMENT; GENETIC SCREENING; GROWTH; HEALTH CARE DELIVERY; HETEROZYGOTE; HUMAN; HYPNOSIS; INTERVIEW; LEISURE; LUNG CLEARANCE; LUNG FUNCTION; MARITAL THERAPY; MASSAGE; MEDICAL INFORMATION; MEDLINE; META ANALYSIS; MUSIC THERAPY; NUTRITION; OUTCOME ASSESSMENT; PATIENT AUTONOMY; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSIOTHERAPY; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; PSYCHODYNAMICS; PSYCHOEDUCATION; PSYCHOMETRY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; PSYCINFO; QUALITY OF LIFE; REVIEW; SELF CARE; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; COCHRANE LIBRARY; GENETIC ANALYSIS; HETEROZYGOTE DETECTION; INTERVENTION STUDY; PATIENT COUNSELING;

EID: 77950140721     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003148.pub2     Document Type: Review

References (152)

1. Chernoff 2002 {published data only} * Chernoff RG, Ireys HT, DeVet KA, Kim Y. A randomized, controlled trial of a community-based support program for families of children with chronic illness: Pediatric outcomes. Archives of Pediatrics & Adolescent Medicine 2002;156(6):533-539. [MEDLINE: 11]
2. Ireys HT, Chernoff R, DeVet KA, Kim Y. Maternal outcomes of a randomized controlled trial of a community-based support program for families of children with chronic illnesses. Archives of Pediatrics & Adolescent Medicine 2001;155(7):771-777. [MEDLINE: 10]
3. Cheuvront 1998 {published data only} * Cheuvront B, Sorenson JR, Callanan NP, Stearns SC, DeVellis BM. Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives. American Journal of Medical Genetics 1998;75(5):461-8.
4. Sorenson JR, Cheuvront B, Bruning A, Talton S, DeVellis BM, Kock G, et al.Proband and parent assistance in identifying relatives for cystic fibrosis carrier testing. American Journal of Medical Genetics 1996;63(3):419-25.
5. Sorenson JR, Cheuvront B, DeVellis BM, Callanan N, Silverman L, Kock G, et al.Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. American Journal of Medical Genetics 1997;70(2):121-9.
6. Davis 2002 {published data only} Davis MA, Quittner AL, Stack CM. Controlled evaluation of the STARBRIGHT Explorer Series CD-ROM program for children and adolescents with cystic fibrosis. Pediatric Pulmonology 2002, issue Suppl 24:351. [MEDLINE: 6]
7. Davis MA, Quittner AL, Stack CM, Yang M-CK. Controlled evaluation of the STARBRIGHT CD-ROM program for children and adolescents with cystic fibrosis. Journal of Pediatric Psychology 2004;29(4):259-267. [MEDLINE: 1]
8. Quittner AL, Drotar D. Controlled trial of family interventions for cystic fibrosis. NIH Research Grant, Oct 1997 to Aug 2003 1997.
9. Wade SL. Commentary: Computer-based interventions in pediatric psychology. Journal of Pediatric Psychology 2004;29(4):269-272. [MEDLINE: 2]
10. Delk 1994 {published data only} * Delk KK, Gevirtz R, Hicks DA, Carden F, Rucker R. The effects of biofeedback assisted breathing retraining on lung functions in patients with cystic fibrosis. Chest 1994;105(1):23-8.
11. Downs 2006 {published data only} * Downs JA, Roberts CM, Blackmore AM, Le Souëf PN, Jenkins SC. Benefits of an education programme on the self-management of aerosol and airway treatments for children with cystic fibrosis. Chronic Respiratory Disease 2006;3:19-27.
12. Grasso 2000 {published data only} * Grasso MC, Button BM, Allison DJ, Sawyer SM. Benefits of music therapy as an adjunct to chest physiotherapy in infants and toddles with cystic fibrosis. Pediatric Pulmonology 2000;29(5):371-81.
13. Grasso MC, Button BM, Sawyer SM, Allison DJ. Music: Meeting the challenge of adherence to chest physiotherapy for infants and toddlers with cystic fibrosis [abstract]. Pediatric Pulmonology 1998;Suppl 17:397.
14. Hernandez-Reif 1999 {published data only} * Hernandez-Reif M, Field T, Krasnegor J, Martinez E, Schwartzman M, Mavunda K. Children with cystic fibrosis benefit from massage therapy. Journal of Pediatric Psychology 1999;24(2):175-81.
15. Powers 2003 {published and unpublished data} Powers SW, Byars KC, Mitchell MJ, Schindler T, Patton SR, Zeller MH. A randomized pilot study of behavioral treatment to increase calorie intake in toddlers with cystic fibrosis. Child Health Care 2003;32:297-311.
16. Powers SW, Byars KC, Mitchell MJ, Schindler T, Patton SR, Zeller MH. Nutritional benefits of two early intervention programs for toddlers with cystic fibrosis: A randomized pilot study. personal communication 2001.
17. Powers SW, Schindler T, Schwarber L, Deeks CM, Byars KC, Arthur S, et al.Behavioral treatment to improve nutrition in toddlers with cystic fibrosis [abstract]. Pediatric Pulmonology. 1999; Vol. Suppl 19:329.
18. Powers 2005 {published data only} Powers SW. Nutrition in early childhood: focus on parent interaction [abstract]. Pediatric Pulmonology 2003;Suppl 25:138.
19. Powers SW, Jones JS, Ferguson KS, Heidemann M, Henry R, Piazza-Waggoner C, et al.Behavioural treatment for toddlers and preschoolers with cystic fibrosis produces recommended energy intake and normal rates of growth [abstract]. Pediatric Pulmonology 2004;38(27):361.
20. Powers SW, Jones JS, Ferguson KS, Henry R, Heidemann M, Patton SR, et al.Overcoming barriers to evidence-based nutrition treatment for preschoolers such as distance from cystic fibrosis center and multiple food allergies [abstract]. Pediatric Pulmonology 2004;38(27):341.
21. * Powers SW, Jones JS, Ferguson KS, Piazza-Waggoner C, Daines C, Acton JD. Randomized clinical trial of behavioral and nutrition treatment to improve energy intake and growth in toddlers and preschoolers with cystic fibrosis. Pediatrics 2005;116(6):1442-50.
22. Powers SW, Piazza-Waggoner C, Jones J, Daines C, Acton J. Impact of behavioral and nutrition treatment for toddlers and preschoolers with CF on erergy intake and growth maintains for 12 and 18 months [abstract]. Pediatric Pulmonology 2005;40(Suppll 28):372.
23. Stapleton 2001 {published data only} Stapleton D, Tunnicliffe L, McGuiness D, Sheriff J, Sly P. Development of a nutrition and behaviour intervention program: Go and Grow with CF. Australian Journal of Nutrition and Diet 1998;55:130-7.
24. Stapleton DR, Gurrin LC, Zubrick SR, Silburn SR, Sherriff JL, Sly PD. What do children with cystic fibrosis and their parents know about nutrition and pancreatic enzymes?. Journal of the American Dietetic Association 2000;100(12):1494-500.
25. * Stapleton DR, Gurrin LC, Zubrick SR, Silburn SR, Sly PD. The effect of 'Go and Grow with CF' on nutrition and pancreatic enzyme knowledge of children with cystic fibrosis. Australian Journal of Nutrition and Dietetics 2001;58(3):164-168. [MEDLINE: 7]
26. Stark 1996 {published data only} * Stark LJ, Mulvihill MM, Powers SW, Jelalian E, Keating K, Creveling S, et al.Behavioral intervention to improve calorie intake of children with cystic fibrosis: Treatment versus wait list control. Journal of Pediatric Gastroenterology and Nutrition 1996;22(3):240-53.
27. Stark 2003 {published and unpublished data} Stark LJ. Contribution of behavior therapy to nutrition adherence in cystic fibrosis: A two-year randomized controlled study. Personal communication 2001.
28. * Stark LJ, Opipari LC, Spieth LE, Jelalian E, Quittner AL, Higgins L, Mackner L, B K, Lapey A, Stallings VA, Duggan C. Contribution of behavior therapy to dietary treatment in cystic fibrosis: A randomized controlled study within 2-year follow-up. Behavior Therapy 2003;34(2):237-258. [MEDLINE: 4]
29. Trapp 1998 {published and unpublished data} * Trapp M, Barton S, Morgan H, Lockyer L. Self-administration of drugs for cystic fibrosis. Professional Nurse 1998;14(3):199-203.
30. Barbero 1996 {published data only} Barbero GJ. The science and humanity of cystic fibrosis. Current Problems in Pediatrics 1996;26(10):345-54.
31. Bartholomew 1997 {published data only} Bartholomew LK, Czyzewski DI, Parcel GS, Swank PR, Sockrider MM, Mariotto MJ, Schidlow DV, Fink RJ. Self-management of cystic fibrosis: Short-term outcomes of the Cystic Fibrosis Family Education Program. Health Education and Behavior 1997;24(5):652-666.
32. Brady 1991 {published data only} Brady MS, Rickard K, Yu PL, Eigen H. Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis. Pediatric Pulmonology 1991;10(2):79-85.
33. Brandt 1996 {published data only} Brandt NJ, Schwartz M, Skovby F, Clausen H. A follow-up study of carriers of cystic fibrosis. Ugeskrift for laeger 1996;158(33):4623-7.
34. Brown 1994 {published data only} Brown RK, Kelly FJ. Evidence of increased oxidative damage in patients with cystic fibrosis. Pediatric Research 1994;36(4):487-93.
35. Clayton 1995 {published data only} Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, Campbell PW, Phillips JA. Teaching about cystic fibrosis carrier screening by using written and video information. American Journal of Human Genetics 1995;57(1):171-81.
36. Dodd 1997 {published data only} Dodd ME, Abbott J, Haworth CS, Moorcroft AJ, Webb AK. Validity of a visual numerical general quality of life scale and chest scale in adults with cystic fibrosis [abstract]. Thorax 1997;52(Suppl 6):A45.
37. Donaldson 1995 {published data only} Donaldson C, Shackley P, Abdalla M, Miedzybrodzka Z. Willingness to pay for antenatal carrier screening for cystic fibrosis. Health Economics 1995;4(6):439-52.
38. Marteau TM, Michie S, Miedzybrodzka ZH, Allanson A. Incorrect recall of residual risk three years after carrier screening for cystic fibrosis: A comparison of two-step and couple screening. American Journal of Obstetrics & Gynecology 1999;181(12):165-9.
39. Miedzybrodzka ZH, Haites N, Hall M, Templeton A, Marteau T, Dean J, et al.Two approaches to ante-natal carrier screening for cystic fibrosis [abstract]. Proceedings of the 11th International Cystic Fibrosis Congress. 1992:TP20.
40. Miedzybrodzka ZH, Hall MH, Mollison J, Templeton A, Russell IT, Dean JC, et al.Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise versus couple screening. British Medical Journal 1995;310(6976):353-7.
41. Miedzybrodzka ZH, Marteau TM. Recall of residual risk three years after carrier screening for CF: a comparison of two-step and couple screening [abstract]. Journal of Medical Genetics 1999;36(Suppl 1):570.
42. Wald NJ, Brock DJH, Haddow EJ, Doherty RA. Antenatal screening for cystic fibrosis [letter]. British Medical Journal 1995;310(6988):1199.
43. Eng 1997 {published data only} Eng CM, Schechter C, Robinowitz J, Fulop G, Burgert T, Levy B, et al.Prenatal genetic carrier testing using triple disease screening. Journal of the American Medical Association 1997;278(15):1268-72.
44. Falkman 1977 {published data only} Falkman C. Cystic fibrosis - A psychological study of 52 children and their families. Acta Paediatrica Scandinavia 1977;Suppl 269:7-93.
45. Gee 2000 {published data only} Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000;55(11):946-54.
46. Goa 1997 {published data only} Goa KL, Lamb H. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis. Pharmacoeconomics 1997;12(3):409-22.
47. Goldbeck 2001 {published data only} Goldbeck L, Babka C. Development and evaluation of a multi-family psychoeducational program for cystic fibrosis. Patient Education and Counselling 2001;44(2):187- 92.
48. Gonciartz 1988 {published data only} Gonciartz Z, Besser P, Lelek E, Gundermann KJ, Johannes KJ. Randomised placebo-controlled double blind trial on 'essential' phospholipids in the treatment of fatty liver associated with diabetes. Medicine & Chirurgie Digestives 1988;17:61-5.
49. Green 1995 {published data only} Green JM. Obstetricians' views on prenatal diagnosis and termination of pregnancy: 1980 compared with 1993. British Journal of Obstetrics and Gynaecology 1995;102(3): 228-32.
50. Gremse 1998 {published data only} Gremse DA, Lytle JM, Sacks AI, Balistreri WF. Characterization of failure to imbibe in infants. Clinical Pediatrics 1998;37(5):305-9.
51. Grody 1997 {published data only} Grody WW, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Fang CY, Cantor RM, et al.PCR based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. American Journal of Human Genetics 1997;60(4):935-47.
52. Gulmans 1999 {published data only} Gulmans VA, de Meer K, Brackel HJL, Faber JAJ, Berger R, Helders PJM. Outpatient Exercise training in Children with Cystic Fibrosis: Physiological Effects, Perceived Competence, and Acceptability. Pediatric Pulmonology 1999;28(1):39-46.
53. Haddow 1999 {published data only} Haddow JE, Bradley LA, Palomaki GE, Doherty RA. Issues for implementing prenatal screening for cystic fibrosis: results of a working conference. Journal of Medical Screening 1999;6(2):60-6.
54. Hains 2001 {published data only} Hains AA, Davies WH, Behrens D, Freeman ME, Biller JA. Effectiveness of a cognitive behavioral intervention for adults with cystic fibrosis. Journal of Clinical Psychology in Medical Settings 2001.
55. Hains 1997 {published data only} Hains AA, Davies WH, Behrens D, Biller JA. Cognitive behavioral interventions for adolescents with cystic fibrosis. Journal of Pediatric Psychology 1997;22(5):669- 87.
56. Hodson 1997 {published data only} Hodson ME. Psychosocial aspects for the management of adults with cystic fibrosis. Pediatric Pulmonology 1997;Suppl 16:113-4.
57. Jelalian 1998 {published data only} Jelalian E, Stark LJ, Reynolds L, Seifer R. Nutrition intervention for weight gain in cystic fibrosis: A meta-analysis. Journal of Pediatrics 1998;132(3 Pt 1):486-92.
58. Johnson 2001 {published data only} Johnson KB, Ravert RD, Everton A. Hopkins Teen Central: Assessment of an internet-based support system for children with cystic fibrosis. Pediatrics 2001;107(2):E24.
59. Kollberg 1982 {published data only} Kollberg H. Sociomedical conditions for Swedish patients with cystic fibrosis. A review of the past twelve years. International Journal of Rehabilitation Research 1982;5(3):345-61.
60. Krauth 1999 {published data only} Krauth C, Busse R, Smaczny C, Ullrich G, Wagner TO, Weber J, et al.Cost comparison of hospital and ambulatory I.V. therapy in adult cystic fibrosis patients: Results of a controlled prospective study. Medizinische Klinik 1999;94(10):541- 8.
61. Le Heuzey 1997 {published data only} Le Heuzey MF, Mouren-Simeoni MC, Navarro J. Psychological adjustment of children and adolescents with cystic fibrosis [abstract]. Pediatric Pulmonology 1997;Suppl 16:259.
62. Leonard 1995 {published data only} Leonard KP, Bartholomew LK, Swank PR, Parcel GS. A comparison of two approaches to education about carrier testing for cystic fibrosis. Journal of Genetic Counselling 1995;4(2):97-113.
63. Lindström 1994 {published data only} Lindström B. The essence of existence. On the quality of life of children in the Nordic countries. Thesis - NHV - Report, The Nordic School of Public Health, Göteborg, Sweden 1994.
64. Loader 1996 {published data only} Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH, et al.Cystic fibrosis carrier population screening in the primary care setting. American Journal of Human Genetics 1996;59(1):234-47.
65. Magnussen 1992 {published data only} Magnussen H, Scheidt Mackes M. The effect of flupertine on respiratory drive in healthy probands and patients with various lung diseases. Pneumologie 1992;46:580-6.
66. Phillipson 2000 {published data only} Phillipson GT, Petrucco OM, Matthews CD. Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection. Human Reproduction 2000;15(2):431-5.
67. Pollitt 1997 {published data only} Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV, et al.Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technology Assessment 1997; Vol. 1, issue 7: i-iv:1-202.
68. Ramström 2000 {published data only} Ramström H, Erwander I, Mared L, Kornfält R, Seiving B. Pharmaceutical intervention in the care of cystic fibrosis patients. Journal of Clinical Pharmaceutical Therapy 2000;25(6):427-34.
69. Thompson 1990 {published data only} Thompson RJ, Hodges K, Hamlett KW. A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and nonreferred children. Journal of Pediatric Psychology 1990;15(6):745-59.
70. Thornton 1995 {published data only} Thornton JG, Hewison J, Lilford RJ, Vail A. A randomised trial of three methods of giving information about prenatal testing. British Medical Journal 1995;311(7013): 1127-30.
71. Tullis 1995 {published data only} Tullis DE, Guyatt GH. Quality of life in cystic fibrosis. Pharmacoeconomics 1995;8(1):23-33.
72. Villari 1994 {published data only} Villari B, Hess OM, Piscione F, Vassalli G, Weber KT, Chiariello M. Heart function in chronic pressure overload caused by aortic stenosis: The role of collagen tissue. Cardiologia 1994;39(6):411-20.
73. Ward 1999 {published data only} Ward SA, Tomezsko JL, Holsclaw DS, Paolone AM. Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus. American Journal of Clinical Nutrition 1999;69(5):913-9.
74. Welkenhuysen 1996 {published data only} Welkenhuysen M, Evers-Kiebooms G, Decruyenaere M, Van-den-Berghe H, Bande-Knops J, Van-Gerven V. Adolescents' attitudes towards carrier testing for cystic fibrosis and its relative stability over time. European Journal of Human Genetics 1996;4(1):52-62.
75. Williams 1997 {published data only} Williams PD, Hanson S, Karlin R, Liebergen A, Olson J, Barnard MU, et al.Outcomes of a nursing intervention for siblings of chronically ill children: A pilot study. Journal of Social Pediatric Nursing 1997;2(3):127-37.
76. Wolter 1997 {published data only} Wolter JM, Bowler SD, McCormack JG, Nolan PJ. Home versus hospital therapy including intravenous antibiotics in cystic fibrosis [abstract]. Proceedings of the Annual Scientific Meeting of the 11th Thoracic Society of Australia and New Zealand (TSANZ). 1994:148.
77. * Wolter JM, Bowler SD, Nolan PJ, McCormack JG. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. European Respiratory Journal 1997;10(4):896-900.
78. Wolter JM, Bowler SD, Nolan PJ, McCormack JG. Intravenous home therapy - a randomised trial in adult cystic fibrosis patients [abstract]. Australian and New Zealand Journal of Medicine 1995;25:567.
79. Bryon 2000 {published data only} Bryon M, Burton J, Tostevin M, Madge S. A home visit programme to improve health status and psychosocial functioning of families with a child with cystic fibrosis [abstract]. Pediatric Pulmonology 2000;Suppl 20:336.
80. Cannon 1999 {published data only} Cannon C, Benitez J, Scarbary J, Taylor K, Guill M. In-home video-conferencing for cystic fibrosis patient education [abstract]. Pediatric Pulmonology 1999;Suppl 19:333.
81. Christian 1999 {published data only} Christian BJ, D'Auria JP, Belyea MJ, Retsch-Bogart GZ. Psychosocial status of school-age children with cystic fibrosis [abstract]. Pediatric Pulmonology 1999;Suppl 19:329.
82. Davis 1990 {published data only} Davis P, Davis S, Mather F, Waring W. A randomized trial of home intravenous antibiotic therapy (HIVAT) in cystic fibrosis (CF): Short-term psychological effects [abstract]. Pediatric Pulmonology 1990;Suppl 5:281-2.
83. Davis S, Mather F, Tankersly P, Waring W. A randomized trial of home intravenous antibiotic therapy (HIVAT) in cystic fibrosis (CF): Short-term safety and efficacy [abstract]. PediatricPulmonology 1990;Suppl 5:245.
84. Klig 1989 {published data only} Klig S, Denning C, Jacoby J, Xia F, Gaerlan P, Bisberg D, et al.Biopsychosocial examination of two methods of pulmonary therapy [abstract]. Pediatric Pulmonology 1989;Suppl 4:145.
85. Mischler 1998 {published data only} Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, et al.Nutritional benefits of neonatal screening for cystic fibrosis. The New England Journal of Medicine 1997;337(14):963-9.
86. Farrell PM, Mischler EH. Newborn screening for cystic fibrosis. Advances in Pediatrics 1992;39:36-69.
87. Fost N, Farrell PM. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: A unique ethical dilemma. Clinical Research 1989;37:495-500.
88. * Mischler EH, Wilford BS, Fost N, Laxona A, Reiser C, Sauer CM, et al.Cystic fibrosis newborn screening: Impact on reproductive behavior and implications for genetic counseling. Pediatrics 1998;Vol. 102, issue 1 Pt 1:44-52.
89. Petzel 1991 {published data only} Petzel SV, Finkelstein J, Budd J, Ellis LBM. Adherence in cystic fibrosis [abstract]. Pediatric Pulmonology 1991;Suppl 6:308.
90. Powers 2003a {published data only} Powers SW. Nutrition in early childhood: Focus on parent interaction. Pediatric Pulmonology 2003, issue Suppl. 25:138-9. [MEDLINE: 5]
91. Stark 1998 {published data only} Stark LJ, Quittner AL, Opipari LC, Jones E, Powers SW, Higgins L, et al.The contribution of behavior therapy to enhancing adherence in school-age children with CF: The example of diet [abstract]. Pediatric Pulmonology 1998;Suppl 17:110-1.
92. Williams 1987 {published data only} Williams J, Handy DA, Booth IW, Weller PH. Intensive dietary counselling with adolescents with cystic fibrosis: What are the effects? [abstract]. Proceedings of the 10th International Cystic Fibrosis Congress; 1998 March 5-10; Sydney. 1988:165.
93. * Williams J, Handy DA, Weller PH, Booth IW. Intensive dietary counselling In adolescents with cystic fibrosis. Gut 1987;28: A1352.
94. Kalnins 1996 {published data only} * Kalnins D, Durie PR. Oral supplements vs. normal food intake in children and adults [abstract]. Israel Journal of Medical Science 1996;32(Suppl):S120-2.
95. Kalnins D, Durie PR, Corey M, Ellis L, Pencharz E, Tullis E. Are oral dietary supplements effective in the nutritional management of adolescents and adults with cystic fibrosis? [abstract]. Pediatric Pulmonology 1996;Suppl 13:314-5.
96. Quinn 2004 {published data only} Quinn J, Latchford G, Duff A, Conner M, Pollard K, Morrison L, Conway S, Marsden R. Measuring, predicting and improving adherence to inhalation therapy in patients with CF: Randomised controlled study of motivational interviewing. Pediatric Pulmonology 2004. [MEDLINE: 9]
97. Quittner 2000 {published data only} DeLambo KE, Ievers-Landis CE, Drotar D, Quittner AL. Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis. Journal of Pediatric Psychology 2004;29(5):343-353. [MEDLINE: 3]
98. Quittner AL, Drotar D, Ievers-Landis C. Intervention to increase adolescent adherence to treatment: preliminary comparisons of family therapy and cystic fibrosis family education [abstract]. Pediatric Pulmonology 1998;Suppl 17:113-4.
99. * Quittner AL, Drotar D, Ievers-Landis C, Slocum N, Seidner D, Jacobsen J. Adherence to medical treatments in adolescents with cystic fibrosis: The development and evaluation of family-based interventions. In: Drotar D editor(s). Promoting adherence to medical treatment in childhood chronic illness: Concepts, methods, and interventions. First Edition. Mahjah NJ: Lawrence Earlbaum Associates, 2000:383-407.
100. Quittner AL, Drotar D, Ivers-Landis C, Slocum N, Buu A. Measuring adherence to treatment in adolescents with cystic fibrosis: Pros and cons of electronic monitoring [abstract]. Conference proceedings of the 8th Florida Conference on Child Health Psychology; 2001 April; Florida. 2001.
101. Quittner AL, Johnson SB, Modi A. Controlled evaluation of a clinic-based intervention to promote adherence in children with cystic fibrosis. Personal communication 2002.
102. Watson 2004 {published data only} Watson H, Truby H, Haworth CS, Bilton D. Pilot study to evaluate a home-based behavioural nutrition programme for adults. Journal of Cystic Fibrosis. 3 2004; Vol. 3, issue Suppl. 1:S75. [MEDLINE: 8]
103. Watson 2006 {published data only} * Watson H, Bilton D, Truby H. A randomised controlled trial of a behavioural nutrition education programme "Eat Well with CF" for adults with CF. Journal of Cystic Fibrosis 2006;5(Suppl 1):S73.
104. Banerjee 1996 Banerjee S, Shamash K, Macdonald AJD, Mann AH. Randomised controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home. British Medical Journal 1996;313:1058-1061. [MEDLINE: 4]
105. Barlow 2003 Barlow J, Coren E. Parent-training programmes for improving maternal psychosocial health. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD002020.pub2]
106. Bartholomew 1991 Bartholomew LK, Parcel GS, Seilheimer DK, Czyzewski D, Spinelli SH, Congdon B. Development of a health education program to promote the self-management of cystic fibrosis.. Health Education Quarterly 1991;18(4):429-443.
107. Beale 2006 Beale IL. Scholarly literature review: Efficacy of psychological interventions for pediatric chronic illnesses. Journal of Pediatric Psychology 2006;31(5):437-451. [MEDLINE: 1]
108. Bluebond-Langner1991 Bluebond-Langner M. Living with cystic fibrosis: a family affair.. In: Morgan JD editor(s). Young People and Death. Philadelphia: Charles Press, 1991.
109. Bluebond-Langner2001 Bluebond-Langner M, Lask B, Angst DB. In: Bluebond-Langner M, Lask B, Angst DB editor(s). Psychosocial Aspects of Cystic Fibrosis. London: Arnold, 2001.
110. Bobadilla 2002 Bobadilla JL, Macek Jr M, Fine JP, Farrell PM. Cystic Fibrosis: A worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Human Mutation 2002;19:575-606.
111. CFF Consensus 2001 CFF Consensus Statement. Pediatric Nutrition for Patients with Cystic Fibrosis. Bathesda, MD: Cystic Fibrosis Foundation, 2001; Vol. X.
112. Christopherson 1994 Christopherson ER. Pediatric Compliance: A Guide for the Primary Care Physician (Critical Issues in Developmental and Behavioral Pediatrics). 1st Edition. New York: Plenum, 1994.
113. Cohen 1992 Cohen J. Quantitative Methods in Psychology: A Power Primer. Psychological Bulletin 1992;112(1):155-159.
114. Coren 2001 Coren E, Barlow J. Individual and group-based parenting programmes for improving psychosocial outcomes for teenage parents and their children. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD002964]
115. Dahlquist 1992 Dahlquist LM. Coping with Aversive Medical Treatments. In: La Greca AM, Siegel LJ, Wallander JL, Walker CE editor(s). Stress and Coping in Child Health. New York: The Guildford Press, 1992:345-76. [MEDLINE: 3]
116. DiGirolamo 1997 DiGirolamo AM, Quittner AL, Ackerman V, Stevens J. Identification and assessment of ongoing stressors in adolescents with a chronic illness: An application of the behavior analytic model. Journal of Clinical Child Psychology 1997;26:53-66.
117. Dodge 2007 Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. European Respiratory Journal 2007;29:522-526.
118. Donner 2001 Donner A, Piaggio G, Villar J. Statistical methods for the meta-analysis of cluster randomization trials. Stat Meth Med Res 2001;10:325-38.
119. Field 1992 Field T. Infants' and Children's Responses to Invasive Procedures. In: La Greca AM, Siegel LJ, Wallander JL, Walker CE editor(s). Stress and Coping in Child Health. New York: The Guildford Press, 1992: 123-39. [MEDLINE: 2]
120. FitzSimmons 1993 FitzSimmons SC. The changing epidemiology of cystic fibrosis. Journal of Pediatrics 1993;122(1):1-9.
121. Gudas 1991 Gudas LJ, Koocher GP, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis. Developmental and Behavioral Pediatrics 1991;12(4):236-42.
122. Ilfeld 1976 Ilfeld F. Further validation of a psychiatric symptom index in a normal population. Psychological Reports 1976;39:1215- 8.
123. Kibby 1998 Kibby MY, Tyc VL, Mulhern RK. Effectiveness of psychological intervention for children and adolescents with chronic medical illness: A meta-analysis. Clinical Psychology Review 1998;18(1): 103-117.
124. Lavigne 1992 Lavigne JV, Faier-Routman J. Psychological adjustment to pediatric physical disorders: A meta-analytic review. Journal of Pediatric Psychology 1992;17(2):133-58.
125. Mackner 2001 Mackner LM, McGarth AM, Stark LJ. Dietary Recommendations to Prevent and Manage Chronic Pediatric Health Conditions: Adherence, intervention, and future directions. Journal of Developmental and Behavioral Pediatrics 2001;22(2):130-43.
126. McNair 1971 McNair DM, Lorr M, Droppleman LF. POMS Profile of Mood States. San Diego: Educational and Industrial Testing Service, 1971.
127. Michie 2004 Michie S, Hendy J, Smith J, Adshead F. Evidence into practice: A theory based study of achieving national health targets in primary care. Journal of Evaluation in Clinical Practice 2004;10(3):447- 456.
128. Miller 1999 Miller DL, Jelalian E, Stark LJ. Cystic Fibrosis. In: Goreczny AJ, Hersen M editor(s). Handbook of Pediatric and Adolescent Health Psychology. First Edition. Boston: Allyn and Bacon, 1999.
129. Miller 2002 Miller MS, Quittner AL, Lask B, Gluckauf R, Glasscoe CA. Empirically validated interventions: Face-to-face and web-based. European Cystic Fibrosis Foundation Conference proceeding for multidisciplinary psychosocial meeting. 2002.
130. Moher 2001 Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
131. Passero 1981 Passero MA, Remor B, Solomon J. Patient-reported compliance with cystic fibrosis therapy. Clinical Pediatrics 1981;20:264-8.
132. Pearson 1991 Pearson DA, Pumariega AJ, Seilheimer DK. The development of psychiatric symptomatology in patients with cystic fibrosis. Journal of the American Academy of Child & Adolescent Psychiatry 1991;30(2):290-7.
133. Proos 1992 Proos M, Reiley P, Eagan J, Stengrevics S, Castile J, Arian D. A study of the effects of self-medication on patients' knowledge of and compliance with their medical regimen. Journal of Nursing Care Quality 1992;7(Supplement):18-26.
134. Quittner 1992a Quittner AL, DiGirolamo AM, Michel M, Eigen H. Parental Response to Cystic Fibrosis: A Contextual Analysis of the Diagnosis Phase. Journal of Pediatric Psychology 1992;17(6):683-704.
135. Quittner 1992b Quittner AL, Opipari LC, Regoli MJ, Jacobsen J, Eigen H. The impact of caregiving and role strain on family life: Comparisons between mothers of children with cystic fibrosis and matched controls. Rehabilitation Psychology 1992;37(4):275-90.
136. Quittner 1997 Quittner AL, Drotar D. Controlled trial of family interventions for cystic fibrosis. NIH Research Grant, Oct 1997 to August 2003 1997.
137. Quittner 1998 Quittner AL, Espelage DL, Opipari LC, Carter B, Eid N, Eigen H. Role strain in couples with and without a child with a chronic illness: Associations with marital satisfaction, intimacy, and daily mood. Health Psychology 1998;17(2):112-24.
138. Quittner 2000 Quittner AL, Drotar D, Ievers-Landis C, Slocum N, Seidner D, Jacobsen J. Adherence to Medical Treatments in Adolescents with Cystic Fibrosis: The Development and Evaluation of Family-Based Interventions. In: Drotar D editor(s). Promoting Adherence to Medical Treatment in Childhood Chronic Illness: Concepts, Methods and Interventions. Mahwah NJ: Lawrence Earlbaum Associates, 2000:383-407.
139. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical
140. Sorenson 1997 Sorenson JR, Cheuvront B, DeVellis BM, Callanan N, Silverman L, Kock G, et al.Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. American Journal of Medical Genetics 1997;70(2):121-9.
141. Spielberger 1970 Spielberger CD, Gorsuch RC, Lushene RE. The State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychological Press, 1970.
142. Spielberger 1973 Spielberger CD. State Trait Anxiety Inventory for Children. Palo Alto, CA: Consulting Psychological Press, 1973.
143. Spielberger 1979 Spielberger CD. Preliminary manual for the State-Trait Personality Inventory. Tampa: Human Resources Institute, University of South Florida, 1979.
144. Spielberger 1985 Spielberger CD. Assessment of State and Trait Anxiety: Conceptual and methodological issues. South Psychologist 1985;2:6-16.
145. Stapleton 2000 Stapleton DR, Gurrin LC, Zubrick SR, Silburn SR, Sherriff JL, Sly PD. What do children with cystic fibrosis and their parents know about nutrition and pancreatic enzymes?. Journal of the American Dietetic Association 2000;100(12):1494-500.
146. Stark 1987 Stark LJ, Miller ST, Plienes AJ, Drabman RS. Behavioral contracting to increase chest physiotherapy: a study of a young cystic fibrosis patient. Behaviour Modification 1987;11(1):75-86.
147. Stark 1990 Stark LJ, Bowen AM, Tyc VL, Evans S, Passero MA. A behavioral approach to increasing calorie consumption in children with cystic fibrosis. Journal of Pediatric Psychology 1990;15(3):309-26.
148. Stark 1995 Stark LJ, Jelalian E, Miller DL. Cystic Fibrosis. In: Roberts MC editor(s). Handbook of Pediatric Psychology. 2nd Edition. New York: Guildford Press, 1995.
149. Sumner 1994 Sumner G, Spietz A. Caregiver/parent-child interaction teaching manual. Seattle, WA: NCAST Publications, 1994.
150. Thompson 1990 Thompson RJ, Hodges K, Hamlett KW. A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and nonreferred children. Journal of Pediatric Psychology 1990;15(6):745-59.
151. Tsui 1990 Tsui LC. Population Analysis of the Major Mutation in Cystic Fibrosis. Human Genetics 1990;85(4):391-445.
152. Watson 1988 Watson D, Clark LA, Tellegen A. Development and validation of a brief measure of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology 1988;54(6):1063-70.